OBJECTIVE. This commentary deals with the study by Newhouse and colleagues in this issue of the AJR discussing the implications of alack of a control group in previously published studies on contrast-induced nephropathy (CIN). CONCLUSION. Until more rigorous studies including an appropriate control group address the issue of CIN, our understanding of the actual risk of CIN when administering IV contrast media is limited.